
Ticaford 90mg Tablet
Marketer
Leeford Healthcare Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticaford 90mg Tablet
Ticagrelor 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the formation of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiovascular disease. This medication is also indicated for individuals recovering from a recent heart attack or experiencing severe angina (chest pain) who have received coronary stents. It helps prevent future cardiac events such as recurrent heart attacks, strokes, or clot formation within the stents. Concurrent use with aspirin, another antiplatelet drug, is typically prescribed. Ticagrelor 90mg tablets can be administered with or without food, but consistent daily dosing at the same time is crucial. Discontinuing treatment increases the risk of subsequent cardiovascular events. The most frequent adverse effect is bleeding; minor cuts or injuries may bleed longer than normal, though this usually resolves spontaneously. Some patients experience mild shortness of breath, which typically subsides with continued therapy. Persistent or worsening bleeding or shortness of breath should be reported to your physician. This medication is contraindicated in individuals with active bleeding (e.g., stomach ulcer, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor prior to initiating treatment.
Uses of Ticaford 90mg Tablet
Cardiovascular event prophylaxis
Major Benefits of Ticaford 90mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticaford 90mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Ticaford 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticaford 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticaford 90mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Ticaford 90mg Tablet works:
Ticagrelor 90mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous blood clots and subsequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Ticaford 90mg tablets with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Use of Ticaford 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticaford 90mg Tablet with breastfeeding are absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticaford 90mg Tablets.
KidneySAFE IF PRESCRIBED
Ticaford 90mg tablets can be safely administered to individuals with impaired kidney function. No dosage modification is necessary for Ticaford 90mg tablets in this population. Data regarding the use of Ticaford 90mg tablets in patients undergoing renal dialysis is limited.
LiverCAUTION
Patients with liver impairment should use Ticaford 90mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Ticaford 90mg tablet use; physician consultation is advised.
What if you forget to take Ticaford 90mg Tablet :
Should you forget a Ticaford 90mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Ticaford 90mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
